The U.S. Hemostats Market is expected to grow with a CAGR of 7.4% in the forecast period of 2021 to 2028. The years considered for the study are as mentioned below:
Access Full Report @ https://www.databridgemarketresearch.com/reports/us-hemostats-market
The U.S. hemostats market is a highly consolidated market, which includes a specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenarios.
The major players dealing in the U.S. hemostats market are introducing a strong range of products providers, launching new products, and adopting strategic initiatives such as acquisition, agreement, business expansion, award, and recognition. This helped companies to maximize sales with an enhanced product portfolio.
For instance,
- In August 2018, Johnson & Johnson Services, Inc. announced the. launch of SURGICEL POWDER ABSORBABLE HEMOSTAT. This powdered adjunctive hemostat is designed to help surgeons control disruptive bleeding more efficiently. This has increased company’s sales in the United States with the increased production
Johnson & Johnson Services Inc. is the dominating player in the U.S. hemostats market. The other key players existing in the market are Baxter, BD, B. Braun Melsungen AG, Teleflex Incorporated, Pfizer Inc., Arch Therapeutics, Inc., Biom’Up, Hemostatis LLC, CyroLife Inc., 3-D Matrix Ltd., Integra LifeSciences, L&R Group, Marine Polymer Technologies, Inc., Medtrade Products Limited, Meril Life Science Pvt. Ltd., RESORBA Medical GmbH, Starch Medical, Inc., Stryker, Unilene, among others.
JOHNSON & JOHNSON SERVICES, INC.
Johnson & Johnson Services, Inc. was founded in 1961 and has headquarters in New Jersey, U.S. It has private ownership. The company focuses on providing surgical technologies and solutions, including sutures, staplers, energy devices, trocars and hemostats, interventional ablation, robotics, and digital solutions. The company operates its business via several business segments such as Pharmaceuticals, Consumer, Medical Devices in which Medical Devices is the market-focused segment.
The company provides products via various product categories such as Adjunctive Hemostats, Energy Sealing and Dissecting, Hernia Mesh and Fixation, Ligation, Magnetic Sphincter Augmentation, Microwave Ablation, Other Endoscopic Instruments, Surgical Stapling, Uterine and Pelvic, Vascular Access and Infection Control and Wound Closure. Under which Adjunctive Hemostats is the market-focused category.
For instance,
- In December 2019, Johnson & Johnson Services, Inc. announced that they had launched VISTASEAL Fibrin Sealant (Human) to help surgeons manage bleeding during surgery which contains a combination of fibrinogen and thrombin, clotting proteins found in human plasma. This has increased company’s product pipeline
The company has a wide presence across the Americas, Europe, Asia-Pacific, Middle East, and Africa. The company also has various subsidiary companies such as Janssen-Cilag A/S (Denmark), Janssen Pharmaceutica (Pty.) Ltd. (South Africa), Johnson & Johnson del Perú SA (Peru), Janssen-Cilag Farmacêutica Ltda. (Brazil), Janssen Pharmaceuticals, Inc. (U.S.), among others.
BAXTER
Baxter was founded in the year 1931, headquartered in Illinois, U.S. It has public ownership. The company mainly focuses on better healthcare solutions and access to care in the communities where people live and work. The company operates its business via several business segments, including Americas, EMEA, and APAC, in which Americas is the market-focused segment.
The company provides products via various product categories such as Hemostats and Sealants, Tissue Repair Technology, Adhesion Prevention, Bone Repair Technology, and Surgical Tools. Hemostats and Sealants is the market-focused category.
For instance,
- In December 2018, Baxter announced the Disposable Curved Applicator, which enhances the delivery experience of its Floseal Hemostatic Matrix. A product line for procedures in the otolaryngology, head, and neck surgical specialty. This has helped the company to expand their product pipeline
The company has a presence across the Americas, Europe, Asia-Pacific, Middle East, and Africa. The company also has various subsidiaries, including Baxter Corporation Englewood (Colorado), Baxter Healthcare Corporation (Delaware), Baxter Pharmaceutical Solutions LLC (Delaware), Baxter Healthcare Pty Ltd (Australia), Baxter Belgium SPRL (Belgium), among others.
BD
BD was founded in 1897 and headquartered in New Jersey, United States. It has public ownership. The company is focused on providing medical technology for advancing the world of health by improving diagnostics and the delivery of care with the technologies that enable medical research and clinical laboratories to grow. The company operates its business via several business segments, including Medical, Life Science, and Interventional, in which Interventional is the market-focused segment.
The company provide products via various product categories such as Biopsy, Biosciences, Bio-surgery: Sealant and Hemostats Solutions, Cervical Cancer Screening, Diabetes Care, Drug Delivery Systems, Drainage, Gastrointestinal Care, Hazardous Drug Safety, Hernia Repair, and Fixation, Home Care, Infection Prevention, Infusion therapy, Interventional Specialties, Lab Automation, Medication and Supply Management, Microbiology Solutions, Molecular Diagnostics, Patient Monitoring and Temperature Management, Prostate Health, Respiratory Care, Software Solutions, Specimen Collection, Surgical Instruments, Syringes and needles, Urology and Kidney Health, Vascular Access, Vascular Surgery and Wound Care, in which Bio-Surgery: Sealant and Hemostats Solutions is the market focused category.
For instance,
- In July 2021, BD announced that they had acquired Tepha, Inc., a leading developer and manufacturer of proprietary resorbable polymer technology. This has helped the company to manufacture more technological products
The company has a presence across Asia-Pacific, the Middle East and Africa, the Americas, and Europe. The company also has various subsidiaries, including CareFusion (US), C R Bard (New Jersey, US), ATTO Technology (US), Accuri Cytometers (US), CUBEX (US), among others.
